Sweden’s Karo gains remaining Pevaryl rights

12 May 2020 - Deborah Wilkes

Sweden’s Karo Pharma has acquired the remaining European rights to the Pevaryl antifungal brand portfolio from Johnson & Johnson (J&J) for EUR58 million (USD63 million).